Evidence map›Paper›PMID 33759752›Full record

Trial reportDeutsches Arzteblatt international2021

In-Patient Pulmonary Rehabilitation to Improve Asthma Control–A Randomized Controlled Study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients with Asthma).

Konrad Schultz, Michael Wittmann, Rupert Wagner, Nicola Lehbert, Larissa Schwarzkopf, Boglárka Szentes, Dennis Nowak, Hermann Faller, Michael Schuler

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Deutsches Arzteblatt international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pulmonary rehabilitation versus usual care for adults with asthma.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Effectiveness of Pulmonary Rehabilitation on Severe Asthma Outcomes: A Pre-Post Study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
    Article
  8. Randomized controlled trials as a source of evidence in rehabilitation: a critical analysis.European journal of physical and rehabilitation medicine · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Observational
  16. Article
  17. [Rehabilitation in pneumology].Der Pneumologe · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Konrad SchultzClinic Bad Reichenhall, Center for Rehabilitation, Pneumology and Orthopedics, of Deutschen Rentenversicherung Bayern Süd, Bad Reichenhall, Germany; Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institute of Health Economics and Health Care Management, Comprehensive Pneumology Center Munich (CPC-M) - member of the German Center for Lung Research (DZL); Institut und Poliklinik für Arbeits-, Sozialund Umweltmedizin, Klinikum der Universität München, Comprehensive Pneumology Center Munich (CPC-M) - member of the German Center for Lung Research (DZL); Institute for Clinical Epidemiology and Biometry, Universität Würzburg; Chair of Rehabilitation Science, Universität Würzburg, Germany; IFT - Institut für Therapieforschung GmbH, München, Germany.
Michael Wittmann
Rupert Wagner
Nicola Lehbert
Larissa Schwarzkopf
Boglárka Szentes
Dennis Nowak
Hermann Faller
Michael Schuler

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the availability of effective pharmaceutical treatment options, many patients with asthma do not manage to control their illness. This randomized trial with a waiting-list control group examined whether a 3-week course of inpatient pulmonary rehabilitation (PR) improves asthma control (primary endpoint) and other secondary endpoints (e.g., quality of life, cardinal symptoms, mental stress). The subsequent observational segment of the study investigated the long-term outcome after PR.

methodsAfter approval of the rehabilitation´ by the insurance providers (T0), 412 adults with uncontrolled asthma (Asthma Control Test [ACT] score < 20 points) undergoing rehabilitation were assigned to either the intervention group (IG) or the waiting-list control group (CG). PR commenced 1 month (T1) after randomization in the IG and 5 months after randomization (T3) in the CG. Asthma control and the secondary endpoints were assessed 3 months after PR in the IG (T3) as an intention-to-treat analysis by means of analyses of covariance. Moreover, both groups were observed for a period of 12 months after the end of PR.

resultsAt T3 the mean ACT score was 15.76 points in the CG, 20.38 points in the IG. The adjusted mean difference of 4.71 points was clinically relevant (95% confidence interval [3.99; 5.43]; effect size, Cohen's d = 1.27). The secondary endpoints also showed clinically relevant effects in favor of the IG. A year after the end of rehabilitation the mean ACT score was 19.00 points, still clinically relevant at 3.54 points higher than when rehabilitation began. Secondary endpoints such as quality of life and cardinal symptoms (dyspnea, cough, expectoration, pain) and self-management showed moderate to large effects.

conclusionThe trial showed that a 3-week course of PR leads to clinically relevant improvement in asthma control and secondary endpoints. Patients who do not achieve control of their asthma despite outpatient treatment therefore benefit from rehabilitation.

Indexed as

AsthmaSelf-ManagementAdultDyspneaHumansQuality of LifeTreatment Outcome

Identifiers

PMID33759752
PMCPMC8129066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.